Cover Image
市場調查報告書

在全球製藥、生物科技產業的非上市股票交易及創業基金投資

Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry

出版商 Frost & Sullivan 商品編碼 296265
出版日期 內容資訊 英文 58 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
在全球製藥、生物科技產業的非上市股票交易及創業基金投資 Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry
出版日期: 2014年02月12日 內容資訊: 英文 58 Pages
簡介

本報告提供全球醫藥品、生物科技產業的非上市股票交易(私人股權)及創業基金(VC)交易的趨勢相關分析、整體交易數量、交易額、各地區及收購方面企業的各種類的詳細趨勢、跨國交易概況、每主要的疾病、治療領域的資本交易動向、主要企業之外地區的交易特性與趨勢等調查,並將結果概述為以下內容。

分析中主要的用語

簡介

製藥、生物科技產業的主要趨勢

主要的非上市股票(PE)、創業基金(VC)交易的統計資料

創業基金交易的主要指標

交易額的規模相關分析

各地區趨勢分析

出口市場分析

每主要的治療領域的資本交易分析

結論

關於Frost&Sullivan

目錄
Product Code: ND74-01-00-00-00

Vigilance and Equanimity are the Needs of the Hour

This study for the private equity and venture capital trends in the global pharmaceutical and biotechnology industry analyzes the various deals in the industry. The deals are analyzed based on number and average value. The trends are also observed based on the geographic region and buyer types. The study delves into the nature of cross border deals and also keeps into account various deal multiples such as deal value and investment rounds. The distribution of deals across key therapeutic areas has been dealt to understand the focus of investors and to highlight the key therapeutic areas in the near future. The analysis also includes geography-wise interest of buyers in regions across other geographies in terms both deal value and volume.

Table of Contents

  • 1. Key Terms Used in the Study
  • 2. Introduction
  • 3. Key Trends in the Pharma and Biotech Industry
  • 4. Key PEVC Statistics
  • 5. VC Deals-Key Metrics
  • 6. Deal Value Range Analysis
  • 7. Geographic Analysis
  • 8. Analysis of the Exit Market
  • 9. Analysis of Deals Based on Key Therapeutic Areas
  • 10. Conclusion
  • 11. The Frost & Sullivan Story
Back to Top